RiboNN: AI Boosts mRNA Therapy & Vaccine Design
RiboNN, a new AI model, predicts mRNA translation efficiency, enhancing protein production for therapies and vaccines. Developed by UT Austin & Sanofi, it accelerates drug discovery by reducing trial-and-error.
